Barclays’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.96M Sell
135,959
-97,190
-42% -$1.88M ﹤0.01% 2125
2025
Q4
$5.02M Sell
233,149
-65,937
-22% -$1.39M ﹤0.01% 2217
2025
Q3
$5.76M Sell
299,086
-112,437
-27% -$2M ﹤0.01% 2081
2025
Q2
$7.04M Sell
411,523
-34,134
-8% -$1.46M ﹤0.01% 1826
2025
Q1
$28.4M Sell
445,657
-44,380
-9% -$4.67M 0.01% 865
2024
Q4
$59.6M Buy
490,037
+30,137
+7% +$3.69M 0.03% 588
2024
Q3
$57.4M Buy
459,900
+59,002
+15% +$8.16M 0.03% 622
2024
Q2
$63.3M Buy
400,898
+15,418
+4% +$1.98M 0.03% 548
2024
Q1
$49.9M Sell
385,480
-57,426
-13% -$7.03M 0.02% 619
2023
Q4
$42.7M Sell
442,906
-74,380
-14% -$7.14M 0.02% 745
2023
Q3
$62.7M Buy
517,286
+118,761
+30% +$13.4M 0.04% 421
2023
Q2
$45.6M Sell
398,525
-55,085
-12% -$7.1M 0.03% 478
2023
Q1
$62.5M Buy
453,610
+38,602
+9% +$5.01M 0.06% 380
2022
Q4
$53.8M Buy
415,008
+136,542
+49% +$15.8M 0.05% 462
2022
Q3
$30.8M Buy
278,466
+68,496
+33% +$6.9M 0.03% 459
2022
Q2
$15.7M Buy
209,970
+157,498
+300% +$11.6M 0.02% 822
2022
Q1
$4.1M Sell
52,472
-3,791
-7% -$290K ﹤0.01% 1356
2021
Q4
$5.06M Buy
56,263
+1,083
+2% +$92.6K ﹤0.01% 1704
2021
Q3
$5.1M Buy
55,180
+36,786
+200% +$2.83M ﹤0.01% 1631
2021
Q2
$1.43M Sell
18,394
-35,492
-66% -$2.69M ﹤0.01% 2423
2021
Q1
$4.01M Buy
53,886
+223
+0.4% +$20.6K ﹤0.01% 1708
2020
Q4
$9.15M Sell
53,663
-17,522
-25% -$2.6M 0.01% 1195
2020
Q3
$10M Sell
71,185
-106
-0.1% -$16.1K 0.01% 1038
2020
Q2
$11.4M Sell
71,291
-51,498
-42% -$7.01M 0.02% 892
2020
Q1
$12M Sell
122,789
-55,791
-31% -$6.38M 0.02% 891
2019
Q4
$23M Buy
178,580
+128,999
+260% +$13M 0.03% 877
2019
Q3
$3.73M Sell
49,581
-4,341
-8% -$513K ﹤0.01% 2131
2019
Q2
$8.19M Sell
53,922
-2,349
-4% -$285K 0.01% 1490
2019
Q1
$6.71M Buy
56,271
+19,887
+55% +$2.56M 0.01% 1470
2018
Q4
$3.97M Sell
36,384
-7,916
-18% -$990K 0.01% 1767
2018
Q3
$7.16M Sell
44,300
-117,809
-73% -$16.1M 0.01% 1481
2018
Q2
$21.4M Buy
162,109
+116,470
+255% +$11M 0.04% 757
2018
Q1
$3.38M Sell
45,639
-96,763
-68% -$6.45M ﹤0.01% 1946
2017
Q4
$7.92M Sell
142,402
-136,740
-49% -$7.24M 0.01% 1325
2017
Q3
$12.7M Buy
279,142
+244,913
+716% +$9.79M 0.03% 907
2017
Q2
$1.15M Sell
34,229
-61,590
-64% -$2.01M ﹤0.01% 2742
2017
Q1
$2.84M Buy
95,819
+16,109
+20% +$499K 0.01% 1754
2016
Q4
$2.19M Buy
79,710
+64,192
+414% +$2.58M 0.01% 2046
2016
Q3
$952K Sell
15,518
-191,792
-93% -$5.8M ﹤0.01% 2673
2016
Q2
$3.95M Buy
207,310
+198,661
+2,297% +$3.68M 0.01% 1485
2016
Q1
$164K Buy
8,649
+8,198
+1,818% +$143K ﹤0.01% 3986
2015
Q4
$17K Sell
451
-49,393
-99% -$1.6M ﹤0.01% 5247
2015
Q3
$1.6M Buy
49,844
+48,975
+5,636% +$1.66M ﹤0.01% 2317
2015
Q2
$27K Sell
869
-1,286
-60% -$26.3K ﹤0.01% 5506
2015
Q1
$28K Sell
2,155
-1,762
-45% -$23.5K ﹤0.01% 5652
2014
Q4
$54K Sell
3,917
-1,288
-25% -$21.8K ﹤0.01% 5660
2014
Q3
$109K Sell
5,205
-895
-15% -$20.2K ﹤0.01% 5256
2014
Q2
$177K Sell
6,100
-38,043
-86% -$1.2M ﹤0.01% 4929
2014
Q1
$1.06M Sell
44,143
-232,660
-84% -$5.93M ﹤0.01% 3189
2013
Q4
$5.54M Buy
276,803
+76,241
+38% +$2.27M 0.01% 1745
2013
Q3
$9.43M Sell
200,562
-246,654
-55% -$9.5M 0.02% 1190
2013
Q2
$17M Buy
+447,216
New +$16M 0.04% 738

Other funds holding SRPT